0001104659-22-023514.txt : 20220215 0001104659-22-023514.hdr.sgml : 20220215 20220215080059 ACCESSION NUMBER: 0001104659-22-023514 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20220215 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20220215 DATE AS OF CHANGE: 20220215 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Marpai, Inc. CENTRAL INDEX KEY: 0001844392 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 000000000 STATE OF INCORPORATION: NY FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40904 FILM NUMBER: 22637074 BUSINESS ADDRESS: STREET 1: 5701 EAST HILLSBOROUGH AVENUE, SUITE 141 CITY: TAMPA STATE: FL ZIP: 33610 BUSINESS PHONE: 646-303-3483 MAIL ADDRESS: STREET 1: 5701 EAST HILLSBOROUGH AVENUE, SUITE 141 CITY: TAMPA STATE: FL ZIP: 33610 8-K 1 tm226750d1_8k.htm FORM 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 8-K

Current Report

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 15, 2022

MARPAI, INC.

(Exact name of registrant as specified in its charter)

001-40904

(Commission File Number)

Delaware	86-1916231
(State or other jurisdiction of incorporation)	(I.R.S. Employer Identification No.)

5701 East Hillsborough Avenue, Suite 1417
Tampa, Florida 33610

(Address of principal executive offices, with zip code)

(646) 303-3483

(Registrant's telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Ticker symbol(s)	Name of each exchange on which registered
Class A Common Stock, par value $0.0001 per share	MRAI	The Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company x

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨ ¨

Item 2.02

Results of Operations and Financial Condition.

The information contained under Item 7.01 below is incorporated herein by reference.

Item 7.01.

Regulation FD Disclosure.

On February 15, 2022, Marpai, Inc. (the “Company”), issued a press release announcing certain preliminary unaudited financial information for its fiscal quarter ended December 31, 2021. The preliminary results presented reflect the Company’s estimates based solely upon information available, and the Company’s final results could differ from these estimates due to the completion of the Company’s financial closing procedures, final adjustments and other developments that may arise between now and the time such audited consolidated financial statements for the year ended December 31, 2021 are issued.

A copy of the press release issued by the Company announcing the preliminary unaudited financial information for its fiscal quarter ended December 31, 2022 is filed as Exhibit 99.1 hereto.

Item 9.01.

Financial Statements and Exhibits.

(d) Exhibits.

Exhibit Number		Description
99.1		Press Release dated February 15, 2022

104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	MARPAI, INC.

Date: February 15, 2022	By:	/s/ Edmundo Gonzalez
	Name:	Edmundo Gonzalez
	Title:	Chief Financial Officer

EX-99.1 2 tm226750d1_ex99-1.htm EXHIBIT 99.1

Exhibit 99.1

Marpai Announces Unaudited Fourth Quarter 2021 Revenues of $5.7 to $5.9 million

Company also announced it ended 2021 with cash and cash equivalents

(excluding restricted cash) of $19.2 million

NEW YORK, Feb. 15, 2022 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (NASDAQ: MRAI), a deep learning technology company transforming third party administration (TPA) in the self-funded health insurance market, today announced preliminary, unaudited financial information for the fourth quarter of 2021.

Marpai expects its fourth quarter revenues to be in the range of $5.7 to $5.9 million, compared to its previous guidance range of $5.6 to $5.8 million. This represents a quarter-over-quarter growth of approximately 19% to 23% versus the third quarter of 2021. The Company also announced that it had cash and cash equivalents of $19.2 million as of December 31, 2021 (not including restricted cash).

Marpai expects to release the fully audited 2021 financial statements on or before March 31, 2022.

For more information on Marpai, visit www.marpaihealth.com.

About Marpai, Inc.

Marpai,Inc. (Nasdaq: MRAI) is a technology company positioned as the AI-powered TPA alternative in the $22 billion TPA (Third Party Administrator) sector serving employers with self-funded company health plans and representing over $1 trillion in annual health care claims. Beyond traditional TPA services, Marpai offers AI-powered services aimed at reducing claims costs, lowering reinsurance premiums and elevating care quality. Marpai’s proprietary deep learning algorithms uniquely predict potential health events related to chronic illness and major procedures to help prevent costly claims and ensure the best care journey for members. Operating nationwide, Marpai serves over 50,000 members, offers provider networks including Aetna and Cigna, and partners with brokers and consultants. For more information, visit www.marpaihealth.com.

Forward-looking Statements

This press release contains forward-looking statements, as that term is defined in the Private Litigation Reform Act of 1995, that involve significant risks and uncertainties, including statements regarding anticipated fourth-quarter results. Forward-looking statements can be identified through the use of words such as “anticipates,” “expects,” “intends,” “plans,” “believes,” “seeks,” “estimates,” “may,” “can,” “could”, “will”, “potential”, “should,” “goal” and variations of these words or similar expressions. For example, when Marpai discusses its preliminary unaudited estimates of revenues for the quarter ended December 31, 2021, the timing of release of its 2021 fully audited financial statements it is using forward looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect Marpai’s current expectations and speak only as of the date of this release. Actual results may differ materially from Marpai’s current expectations depending upon a number of factors. These factors include, among others, adverse changes in general economic and market conditions, competitive factors including but not limited to pricing pressures and new product introductions, uncertainty of customer acceptance of new product offerings and market changes, risks associated with managing the growth of the business. Except as required by law, Marpai does not undertake any responsibility to revise or update any forward-looking statements whether as a result of new information, future events or otherwise.

More detailed information about Marpai and the risk factors that may affect the realization of forward-looking statements is set forth in Marpai’s filings with the Securities and Exchange Commission. Investors and security holders are urged to read these documents free of charge on the SEC's web site at http://www.sec.gov.

Media contact:

Erika Beerbower for Marpai

erika@lightspeedpr.com

407-758-2727

Investor Relations contact:

Dave Gentry

RedChip Companies Inc.

1-800-RED-CHIP (733-2447)

Or 407-491-4498

Dave@redchip.com

###

EX-101.SCH 3 mrai-20220215.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 mrai-20220215_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 5 mrai-20220215_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 6 R1.htm IDEA: XBRL DOCUMENT

Cover	Feb. 15, 2022
Cover [Abstract]
Document Type	8-K
Amendment Flag	false
Document Period End Date	Feb. 15, 2022
Entity File Number	001-40904
Entity Registrant Name	MARPAI, INC.
Entity Central Index Key	0001844392
Entity Tax Identification Number	86-1916231
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	5701 East Hillsborough Avenue, Suite 1417
Entity Address, City or Town	Tampa
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	33610
City Area Code	646
Local Phone Number	303-3483
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Title of 12(b) Security	Class A Common Stock, par value $0.0001 per share
Trading Symbol	MRAI
Security Exchange Name	NASDAQ
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	false

XML 7 tm226750d1_8k_htm.xml IDEA: XBRL DOCUMENT 0001844392 2022-02-15 2022-02-15 iso4217:USD shares iso4217:USD shares 0001844392 false 8-K 2022-02-15 MARPAI, INC. 001-40904 DE 86-1916231 5701 East Hillsborough Avenue, Suite 1417 Tampa FL 33610 646 303-3483 false false false false Class A Common Stock, par value $0.0001 per share MRAI NASDAQ true false EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.0.1 html 1 122 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://marpaihealth.com/role/Cover Cover Cover 1 false false All Reports Book All Reports tm226750d1_8k.htm mrai-20220215.xsd mrai-20220215_lab.xml mrai-20220215_pre.xml tm226750d1_ex99-1.htm http://xbrl.sec.gov/dei/2021q4 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "tm226750d1_8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "tm226750d1_8k.htm" ] }, "labelLink": { "local": [ "mrai-20220215_lab.xml" ] }, "presentationLink": { "local": [ "mrai-20220215_pre.xml" ] }, "schema": { "local": [ "mrai-20220215.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" ] } }, "elementCount": 59, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021q4": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 122, "memberCustom": 0, "memberStandard": 0, "nsprefix": "MRAI", "nsuri": "http://marpaihealth.com/20220215", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "tm226750d1_8k.htm", "contextRef": "From2022-02-15to2022-02-15", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://marpaihealth.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "tm226750d1_8k.htm", "contextRef": "From2022-02-15to2022-02-15", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r11", "r13", "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r10": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r11": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r12": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r13": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r14": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r15": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r16": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r17": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405" }, "r18": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r19": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r9": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" } }, "version": "2.1" } ZIP 14 0001104659-22-023514-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-22-023514-xbrl.zip M4$L#!!0 ( !U 3U35V[$C8H&'==^%YM]EJ M6>#L],-[H)_Z1PC!%<$TK(%+'L 6Z_,3<(LB7 /7F&&!%!E>^-ZMSQ^_7VI&)S,7!\U_6\?&QD^X6T#7DM"=H(5UQS'8/ M23Q7UKMD"YXPJ1 +7N%#-2Q MP%+ST@S:VI 3<\@&4H!HD-#].(M02BFYH3BIQ=D5?=/!?9#V6\W40L.2Q$P\ M*[<-!>XWK$@@ HLK^J53LW65%! CO:7?TI-?/8W<<2&!1+"FLC8/M B/L5!$ M%^Q2TV>A$V7HWY;< .-'6L#Y%RE3U-LW94W!]#_FVC;ZRTGF3>(LNB1_7^VD MNDZ7"P786EMNFY;9G&_S()7:0C%OL.!!8X*>KT>+/97A(M)]@EBY+F0ZF2A86N- Z))SUK\4;XDG%#@CHU66' M2CA&R$B[1L??$M3?F.F[/*A$ IXP)69IACL6R3*E>$F/8^^;6?WR[W8I!2N[ M$/,S\(;B*/^7.#20S:51=S)-O?P#4$L#!!0 ( !U 3U1^!V)3_PH &R' M 5 ;7)A:2TR,#(R,#(Q-5]L86(N>&ULS9U?4^NX&<;O.]/OH*8W[FU#IY*X@& ] MK_S(^D62_TC^],-^FZ)GPK.$T;/1].CC"!$:L3BAF[/1U^7X?#E?+$8HRS&- M<+>I\'_+\ M*3N=3%Y>7HXH>\8OC#]F1Q';#LMPF>-\E]6Y?=Q_K'[*\$]I0A]/Y:\US@@2 MQXMFI_LL.1O)_5:[?3D^8GPSF7W\.)W\X^>K9?1 MGB<4'G<(C)243(76]ST MY.1D4J0JJ:'4<1[G* MK2C*V4Y5]XPCWH*6"DF$1/=TU,^3LM#68;?<[:U[K8J.;,D_I:N MZ_CRT(A= $9;,DXRMN,1>5/---U"1ZERM$V%0@ZK"!U_78Z^+S3H5Z7Z]Z?) M(1='E2V&0KLMH?E*Y&HI13O9557;3*F:;J8%4=$60WH]*PF2&@^5?"YV'DL# MERG>6(J@I;NJ9JLM5<^MQ" JVN9(K^E:@Z3(9U5_(5G$DRD>>&.]"J"US38[-I Y,4Q,4)Q9C(!ZE%I5BCU3\ M?2?.Y@E/7WO!,)2NV0"LZGAHLJ (L7L#(:GE_CE9<4RS1#9FO:"84N>G(8!9 MXY1$TP7%"F ./E6I]?YI63Z0-)7W###M;UAL8M?$P(9U9DQE4-2 ]D!NB@A4 MA82%SL6S'+6+H=/ C?T/@$R;'WJH!C"H&"!W(' E &*FR+$.S3_))@/0Z:A] ., M8=6.2RT+$!;=6Q\J4N\-E/F.\Y9SN/>!I_K KH@8.DQ9]SM+>4M M6#SV1A]6Z[)MQ20%/BB@_(G.)"3P^"!\"4SD$I0U*'2J&WVE=W M%6@N'X0$BZ3+W%)@-]DFH:T)B :K,8"(@[9X+M4;%7/12G&<+FA,]C^15[!L MALXM%X#--AB:*" R[,X -"HQ*M1(R+W!<:ORR3JZ39,H5L\(*-M/G15 M0( U@!"*C5:+N:^>Y45WB]B 6QRGY3/E_>0 NK= M-CN\T-( X(GVZ' $4B M"+6C?,.TH!'C3ZSQN,2<[41C^#IG,3QBZ8ER"]:@(K3QZ@P)"+(A/@'46J$? MRF=:$)-S@XH,D,S!&W7G<2P.5E;]N4HHF8+'P*IU2UB'W397%F% -,'N (8J MY0?U "(RO?>YLS%QQN^8B^V![Y!I1=L3*M6: ZR\) QO/4!(P/D^$:&^$:E M&&S=\%O.GA,:P<-H2.X%&L"TE1Q-&QX^=H-]#-6#9!7G&Z1JL-[[95$R/ZU- MVZ2]J2DUX8'2-M;;R)1JWUCMU-W["HAB!K6W1C=MDKW4*._ M\"07>Y^S[79'JSM#MF<0 9VKFNZTJ6K=*@J"@"YG.@V5%K7%'M!8LC2)DCRA MFY_%R2E/L*UD-I$K*&"#B@A3$00.H"V=A8,0*:4'$&XYD3 241G%A$.YR!&_ MN;^W]OY=8E=@]!M6@,#*($#IM:<#(P+&42,"E2&HB/&/SB++=H2_"2!+B">, M0/, 3(8^1*0@D[U@E8&^^5J2:"?ZR]?I;+U*\M1VXFE*G/5/@+FZ=]+2@^ # M,*7S4*0A=H^FLS^M_XQ4E <$KMF*8[FH[?)UNV8IL!*65>4*A Z+B@6+) @< M8%\Z$=<,55)4:GVME-4R;"F2ENX* JLM5?VMQ" JWN;(: 1:]>VQ^;_81P_" M& $F.]AEKKL!FTF]*VAJ@L"@PYAQLE))D=+ZFNQPZ,(V_8."C;=!P:9G4+ ) M<5"P&3HHV'@=%*A=E\N4B#;J9ITF&PPLFMBI=@U&AV6=$8LT*%Q@?V#;48>@ M0XR/U3:+9=?DJP3XMO!P*3Y82@KHG*VWV66S7G#3)@J"DRYGQI*;Y4)X#3&2 M:A]L[.(D)W%IZ#*AF$8)3NNE&VU7S_M#G!$ST'P-3X\^#(Z&F320*L/4&HMU MX&$93A^7WK=/W?38;C]X XB#0&J( M0^#Q&QDT?I112(555\N\T?2-I3N:8U[,8>>V%@K0N:4'L-FF1A,%1(O=&4!) M+4:EVM^D\'+UBGK@5;XS"2PD)'<\1;S3M#93W*H-B)M.@]"\\6K-D<-XN8SR M.)TS)_)=%\DS^8)S7/D#RPS)74_@[#*MS]RT:0/"J-,@.%>SCI'+U6#%E==E M:_A<#+\VK./IN/A8DOX1G1W/W+VDC]4:\B"Y0/4;OGH MM-SFQ"H-B)D1)&<<%&.UFF,N0VC+K'S M-Z: AHWWIAC*(&#JM0>_0Z6.0"K$ SDW@F7>/,MH#?01 0!:8K:-F^0H@*I3<&/F/Z MR'=/>?1ZRUE$B'Q:*ZM;KKYK= .CW7+SIB*UB1H4&A!K;_$+4'C( C7R^-#H MO7Q?\),/H\L5YECTN'S XB#>[/),]JC"''S%O#/(\:V( 070;DAT1 2$WP"; MT,V)(A(5H1]0&8P:T1[/V[+#ZH0D_OQZ1^X)EW,:5F2??Q8[>^PX\Q@0Z_JL M;G!Q]).\WL @0'RK6^@4,$/-#-!:/F=698%^E9F@(A?;>]J;FZ[$)[%9;1*_ MUC@C8LM_ 5!+ P04 " =0$]42:0K)U8' #)6 %0 &UR86DM,C R M,C R,35?<')E+GAM;,V MW4M'V (TD25.D@/\]R?9F/+#DI>7;C*90,Q*VN]GA>RU)%^^7:4\>J9*,RFN M&IW662.B(I8)$[.KQN=1\WK4'PX;D39$)(1+0:\:0C;>_OGS3Y']N?REV8P& MC/*D%[V3<7,HIO)-](FDM!>]IX(J8J1Z$WTA/'-'Y(!QJJ*^3!><&FH_*!KN M1:];G2Z)FDU O5^H2*3Z_#C8-LI2KI:JF2YFBA>MG'>+MW9UFP_90'['4\T MZ^G1>;?2V MK:9$+0B;4\+-W 6M[0S:?6D[I?4V+SI7='K52!5AMH6N_>V\=O7_NF=DU@O; M.35S?:L1M??:7BBJJ3"YW#M[8*\(71G;I6A25N3:/\4[PXPKL.DTG:CI>EB6 MVO;LV\)RXTSI#I?QG@?<14(>R"U[=V6;S-6=A_ MO^6-74^T420V96V<3"C/V_AF;0Y,VC_(LY+(V-9:[=B^Q:%?NP&\5G$D54*5 M95[6152\%[;CCKJQ:"^(LA4UXSGCVXA/E4Q]A#8TI,?175BVB1]']-KZD#@_ M!IS,JI$>F "9=C"@5JK!I/J.ZEBQA6-3 W?/$LBXB\JX0AL"ZO)[]$AGS/GL MW'&G8NH.AL<(3Q$@_'/,42.H%C$*UT)DA#_2A50U\/90]$_SLF>K_.%P+_]MF=]^WI!LY_IP@P!'^\E! 0O,,E[%*(SOQ4)E/C6%)PCX0,_D(>(>\!T3'CAU< >TV'D%>90["BY M::U,=/3_4*+ X'>,H=A1TM4:B0C0^YE2>PX%1QB_-10[2J):)Q*!^ZTPS*S= MW,&G+)U\O_&ZS_O8"LH9)3GUB4+C6]Z9$,9-BX08'UI".:/DI"%Q:*S[5I,B M?"@2NOI UR'81Z90VBBY:% >&NX'Q5*BUB,6UP\@Q[90X"@9:%@@&O$Q60T3 MJXQ-63')6 _>6P3*'R7]!,E%"\-0Q%(MY,[MYK[,['=SW9=)<(BO*0@-"4I> M>H)TM,!<)XE%IC;@N2:\( 1DOB#TW=/0=^'H4?+56IDO"/WY M:>C/X>A1GWWNU8.2SZQ8@U5' M_J@$%#]B*AL6BQV#SI#>'_LD7=56:U/90[8H(; M$HIQ8[*(O[O)X5NN=& "98R2TU;*P<#J(JTH\7?C?0LH5)1$M4H, M,[Z>90 MYE($[^4>6T'9HF2P6I&.'5K*OLH*!1DD*_, 3*#XJZ MB%-[:9ZO&7,[']3]=.H;B4/V4.HH.6&]4'SZ0ZTSJDZ-044I:"10TD.H:(PQ MA\:9'0;7G>YD[';Q>$:<(RLH;Y34T"<*@>\G.5;$[24 8: MBV/)U T MVA3!5\KY!R&78D2)EH(F13H0FB7P%H%& G%.LD8N6AB^2)Y94BI?@*H\WP6/ M*10[XERD1Q[>>L]B4?7V?%0\CF0S/Q1\80HDC+L&ME(8&>I02SF\RS035P7'F MP! *&G&M;:4T--"W*54S.\B]5W)IYIO]IR'@G@)0\(@K:H-2\0*P^K[OO=B; M%Z1?80U^H@(B>J](S$>&Q+%;J%&I(?]^ 1I.;]2.= M4N660(SIRMS8QI["%TN XM 8H3X9"8RA(E27[2-==_: >R9O\8G[XYX[:X_\ M#U!+ P04 " =0$]4@Y3S6-T2 !09@ $0 '1M,C(V-S4P9#%?.&LN M:'1M[3UK5]I*U]]=R_\P+^?M\]IUY!)N"EJ>A5PLMMY V]HOKDDR2#0D<3(1 M\->_>T\2"!!0VVC;LTY/CTAF9N\]^[[GDN[_=SPTR0/CKF%;'U)*)IP2:&C59P.BG%5?!6F&&;)O M!]W/L^XBOO^L:U9P:KE]FP^I !DBI%(ZET_GRQ$@:9=I^;&?G@2SFZZ MH(1PEH0S/U-L5JD[Y;C.%M@=XH0&&)%7[HMA5\[Z*P&7L] :=O3<] VESK1S MG[JJ[!@T2+CIG!*A&EJX;3(W=HQLB1FDV9XE^"2>_J!1#@L'N%PL(X"',;"/ MN_7.M.^0Z33E+]NWSSL%X_@P^DC:33SQU=*%WC=*\7IWD= M3O,%L(KMZ:@?&5YJ73/0/)@#_&U9P,5) ]C#J=FQ=#;^Q";7.?!.N\5BH9)_ M"=Q*!&Y]R"P=_A=MD]Y<]ZGILA> *A\ KYO7RG7@-'R8\.@E,/+7O0'ES+W. M7TL?Z0-QY;.7P&DB+6$&!IOMZ/11=]2IO;0]05=(A*2=BSWU/$@ED#*F948[4A59NIPWYV M#L7/8/4=[(<4..6J:H/[H994DR@]&E!F[>BIH%N ^/J1<8^B8S'<9 :IYX#XZU_9X MB VZ2:VH!LP@AKZ6&:%K"X6OL$XD5-AL:<?DT+[/%P3-T MV5A\ 38'^&OKRU1 /L%%DPI6FTTAA#1K6QH&HEPQ*&Q9)&N.@/!AP-)Y/GN6 MX3,9#'*)FT-&78^S6F"Y5>@3 @N;YE$@M!7P?3>P$D7 !-GIAW',W,T2'G - M(,9EWN)8:1!4V#S2_'(>+-(8!S6"M,DL>VA83Z%]FB^+>., A^US7%AB:&"A M$7OTW4/H-?>S,!X^\;]])_2T$)AO#*M*C0Q=## *Y-ZEYD:K-@?2_-$')M7N M2!X"A6N;AKY'@L80DM^NS-HQM*1=XQ$"%SR=48^3#'Y&9I"=F\)S6> LQ+'\ M4W$L9 @ZZY/8(FFZ:F<0./-' WC*=JER>=BU:3]"[J%ZW>*^/JM1J7WDE,SBJY YESIM--6_,P4<",_UJ; MIL>S1/GQ]/Z35;P:#7(J!7 _FRE%\:5JN^E/BVG)?A8IA0^U]@_A?\/CD/,( MTF6.S<7:B163PAG.[=69"+C./.YZ%"8H;!BH8>U/E *Q.5%*6_I[8O>)&#!L M\K@A#.9N;K3&VH!:X$OKFL!VI5(HO@VQ;\883,QP:K[4R5;XG5$(NLP5A#V@ M4G#9S/3W5:Q\:HMFJBR8Z9G,[%I^WA=OKT[CK%#Z?OFHWM[^L+U&:PP=, UA MW$"GDPE0SZPX>YXC+%5K,Y5[E$] !;8)0O[GF_FBZ$J!Z/S:L,MN#!<7R 36 MRO&2:SU6V'U^Y_SK01*>-@YOJG9<[Y[5.]ND<]+(_#J9;+7&%"P?B46;X%,B M"76)ZS -RRV=&,!/X1+P%6 B_/VO593$7-"BHK3F%*5MF P$HC(>KR1J^TMG MV&!U9IF)*('A@7AD;-]EF>YQ1M2=9GRPK>F%/P MCJ79'(*>W"3H"0@7#7\YO&'K*QSC_:=\Y6)TWK(_*DF$--S+P 47P1QN/Z Q MS,>T9] )\9V9= 31<*V9"#T!]A7GV'=!QYU@04J3I*US%MI1TST65N]&V4G, M6:P@ )+Y6?$<^')TIW1VSI5O.[N)6>X2ZE3M@@X=NLY&\H2./)Q!J%-/FAKXT>S2]Z/P79[\3-_LS M&\@POQO.FB!6H:7^>& .C+ND)3J'/54K%,I*[A)OW8(*1GZ\9 M?,F H-P8,.U.KIE2!P(;^%#,855[3%1FVB-D 3;*=?W=]*?-C;YAHO89+JBB M8 !-Q[58UQAZIJ 6LSW7G! 7TDVW/Y%#@P&V"M.C82Z,#9&5& _@ -^M2=C6 MMTW CN,PVAI85+MD:]^HN0RK(&#)(;,8!U_?L0"&YR?9]4P^X]/]OOK:C/NA M>OL'*0GJZN6J>G&_< M\A5X@'QQEQ/W0A "OG)#@$KA.HIG!26+&Q\'2O>M8_/1ZSF'6V)) M\H6_N[Z2 M?"&7@9[O@V)25G?1VNZG;<'_F9D)?VH5_YI$HB81UG$]&Z(A2-JZ.0:_#,[9 MC+>'JZL=XW/E\N[@I/BJ]K!,3X+&, ,.4O6A+UN"4J1I)1\QAG!_;\$4BKF, MW_5?:_CCK:$<6,,99^B)\5"?W-?'](.?]ONKJ@5^.>P=]B_*K?KK6L5JNA*T M#D"2UB)8GHP92E%/Y[?4][ZM;&Y$C84LVXK?^5]K^>.MI1%O+1W7]1A_TF;. MS>)%N7/WT-GMOZ7-+%'W2RVGP-+%+>V9EA-T_DTL)^ER!U',\LV@:&,+?@%"1/=*8%VTE57V7Q MFE2J=H%W;_QS0-J :"9UW36[3>OPYI67X=7N\/3[9*C:YI:[;HMK'=)"^25( M3X+S'7*N+#164,G1P- &X7[)3'UCML&>+:IU2_6!K4R4O"KY'^]EA\5#89[V MQ[Q=26 A=WH\G9+-ISR%,U?#NU@NF<0$.:G$J M[04AADY_]3FJ?JO?+'QROY4^EQ/;94+M7=Y@BJ,)U=[5Z?V*:9,&=0P!5=0Q MY7=,+.Z))[SM^XN"4\?2,9(SHDZ()E MD!MNC\0 ,P('EQ^I2W36!X6_;0BKZ;SSSVB.H6**<9L8 1NYBU#:[)KW-RX&8BEA569([=62.:G M4F%_!S,$?2@A-WS \69=/NQ\J7_R2G=JHI6CX!Y;WEF-I4M*()][,O]]:_F\ MA47WR6H3Q2VP!8/?W) 6;RQM*PS G)D)J2F8LV7+1-5SF>P%2(/-"[Q(;LCD MU;_*AG*3R,P)8I<;QZB %LP'6CA[,%P8!TZ"6AHN45%-WK&&SIL;>(U?IUQW M_7T+?56:7-BBT\/J4>O/$+_J^3%U+\^K^_AB.C?_R'2\KG<;=GMT6BCT3Q,) M82LKOE54/;?2>SMG]RMNDT5NB\7>)HO<-DON-MEO'R_F4,3)!^>U!Q#N/:SN M 9$_27GI<)G?*R_H1:6)][R6Q%E&1L=+,9_KN)606P0#J#L2VNV:?,J5G>"A879 MT\7;7/$9@E;>Q:[EQ9SQ3NZT.!0@'<&&))_)Y:-G^\(B)8[0WKYK,3M$O MITMK2)J3T,I>4*3B@>'IBVYD0*:R/O%WP*02[62@E _.:^"YC/!\,?2"$HA! M)0.ITO1]")G7S1U?+(T_VW&\OH_PV84R7K*MM9[BM9W"C6?Z.MENDJ;A:J:- MKPKXU_Z?9_^G>$MH\>;B-J[4.-38)AU+RY M+ _^\]*&WT@1HFZM"VC#YQL'!6 MYA0_%&:F3G0#-Y1('^H7' -,FF(DNL>P,$-0LN9C0M[?"DJS..A^O$-M#XZG M:4P'O0=5\7%3'14"]YG\&.E?!M'9 _AGQW\L!E2 1DT(Y5!+@N<6(\8L*%%' MTWD!?>#Y74^#XC,0&+A^F:W2.>D1>2;=AXNRP\%X=7:MQ/#P:*! B:\B_915 M_(:&6L=#ML[T9.*\M05&J$ZBZA*U0;%@&3'V1YYK?IL;L=+,8]#O&R8Z Y>T MQ@-#-02I5#**C/["_JU%_&_T?T[TK_QFT7^6^/=F[@=]5Z!^[ANE 6_G2%9B MPM=.1&;]^@A_'P.:+E7!0Y,Z+FA(^-N3MN4OCT6JTVQ$)U/8I\=^V)X;Y?'FG ME-.5:S:N5-)*9B"&24X,H]-T*G2!];&,?D/BSF2([P8AWL^W8EXR,D_]\X61 M>FJF3SU,7NZ)L4[!=SG$6-,*D2:&MV$# ^1B,%1.D#!135[_:U)!B7P7PQ;F M33IFQ+BA T41)F8=^3YA@B\4)GKPP/ ZA4IM=;K')[4+RZ[ M^*JW5[Y]M9Z0UWMUTG/3U.B;IOQMQ7O/X'ZF,ZT/(P<"XO;PMV6G[OR&I.Y! M::M1#PM=N9_O7R=#/"HC+K (&FS_;30J&U"S'Y87W-#PJ.> M&-@<#"+1>NX/2$%>F,/'QW B#;_(95/.'C/OP'IY='[I<2_,$BLK6_\5X0D MQ@U\5U>5^ 2N#J9K4JM2HN0<3*IKD2YL&*J+&X;A@P?YM=_E?;SYZ61<:M_E&IV'[HE1=*ZZ5_<=7FE[1_I@ M.)FH?W_43/70?&A]_]K^_IT7OW?.OQN]:%RFXN*R;KNMHT-] M5[4G;96W3SMB]_"H.:-CF@7SY^ME]F[E:JQ]OQ2YT7>;WC;$8%SI3<9?FT6EUW74E"EJ^^?>I/7A\/.TV/SM'XZ//CF*5N'I;.J]GC^FP M.^>5=\$\F_#]02P,$% @ '4!/5#*#)^_)"0 O"0 !4 M !T;3(R-CWNT?XA/XO]Z%\<7[X[ZO?7PB;OKU>W>PIL%(XN5"8M?9!3.M.9R%MAH47GTJCA"E[$JZ?U>TY>N4BD:I3O MDE&CL=NC3)B1PM>-E7[OH']T-58#Y6AGI]WIK1_ D-.OB(AE[J39HV\UI]86 M.5U 8S%7'PVTDB_O&AOD]/\N4.92E.E M<[K;8P]K]G'_M8(+-I:F"N;'PHZ;#9$G_HKDEU)- M1 I)%J8>/X&IJ_(J3N'2?$1&6F=4S,YE8]:\$SL[[6[MO:>QJ,ZM1]/UN;1. M#6=[-!#QY<@@.$D4ZU2;79J.D5LK_0]'_Z)/)V?_:-$;.6A3YT6+0]9M-M9/ MSZ#13I61ZQ1%%/*S1<=YW*;5YU]*[?;"6K@F;5@)>U0+:=#%6%JKQGF6P 035,8OT!/^KK<.NIH@GY(BB M,/I*(> RG5%GYU<6VMW\E?"XA6:V.B3DS>!#F:1[(-&-A6-<'(OD:UAX$XE( M^+5#&N[_[=S[V)]. MI^W,+P:L;:-8>^L?^P_GH*?:,@C8_D"7[EJ;>T0&M:RXWN'C*ZLV%UKX!V$3 M\:5JR02,%'>TX6:CT @V$@#%(@+T[1]'A9Y*QF2T7L <$#!'DDSFD/Y+MTN# M"K[XD=4+CY:GOGWO+]JW-FOHV#$^\6$F#&,R*U(] \X&TKC4SYN-FAI4C;U( MP1"(072.[BR!01T0"@)160"C@,(ERKMZ,48_H3@5*K-M.I S#1$P)_'[Q&-L MLK**'0[9JL?EFHWZ&((G=XV!(4L9L1) .+UH'$2F_$4!ZP49@( ;L>.NF H76FL\-CI7,<%GN;3!J$Q\1F2@$^VK-*%O MCV5:^!X, 7Y[4%-M%J\T&Y+W)WT6#-"1PG8^@PCD$((Q,ZGPB11 MJO4E!^9\W@Y_.BCTK)!1P];T@)/ "=0GI^DU-RQ800MU9@.3 ^AEC)J)!'W@ MB3= WZD!DW.2W@%,1J%SGC&'R&@?A0@BU]G9P8P5R& ^T2E0T\(T-50QTH^, MLI_FY Z9?<_&4*>Y MY^0) \50>;X*!C(:^UV5UA-LE%EBR9;@0G##\S1A5%HHMJWGQB\U&_7-BH75 M-^IE;$KFR:UEC^@W%P<8S@ WM]:ME)>W%@$YGK??84HF9C>?QJ9O+>DR3:JU M5KTX!2K>7)MCZLT;=LPB;LH=Z?F3@?A/A%$^/SR]AY/AXN!?[H881U-AF,1R MBO)3 9?DE4"#!$Y.Q[(F9)0H&Y?62EL/2/4TNS3,SAW#VNI!;#',UJD2#FUN M#1NM,/.PV%$0$$H&EZPRL.AKQ/I.3@T 1<64EJ541495+J*;SI]KHV1$XK&9 M&[4H*_[! P]:$+($[1.5#[]2O,RBD;I&#E,DY&I?&X#&T M,)^S56PX5+:0XA(:>'MUM"CA*O?7:@XA;2YR)AI5Q0&)T*<5]RMBYR/B[*.A MT=D]VFE9>;.1R (1X6V4!8^"E)<^+M [%,R;K!\Y>=OA:P432!"1:8X53.6> M*1*>7>',,0_+_!B-)'HA;)7 /9VA]8>6STR M<"&^PV4!S88G 5!BKYD==M>J4=1:C11DJWS'1ZL0(W_X=I_HO>6T I)5FOG8 M2+FD#BRR.E4)##B]+N_6CP&]=>B\0_W "NB<&RP"\;)-B^;]/(.B]C,[U6Y MY)AU]DQPQI\][N^9=B>8;U3J*=7B^$$L3>>^Y)'QH#^H\SGT>4[%B"N #0 9 M?[@(EJ[^79U@#+]6>T!Q"PC!$_[,^"8^#U'4C#8>2%CRN01D*^9FH9\#-SSZ M\/%?IGS/;M-Q#N+BC?-])+R" 5:G\_96FE% 39B:5#TLT7$9K!H:Z;$/LLVH M[G)T?O3ZKS!%#D 4&%7\8(]Y M681!(':[?]ZA9Z5_9-2EH ,IS8 /'_SH'5+Z 95(5O);RK_=@B/)I##A!/#! M%&QM;$?;+UY%W>WN]A_W3'&E7]T"IO3N^D^JZ+Z<0.H5YV0\LL/F;??9DTG>K6Q$9T='4:OWQZ?TNKV MYF;4W=K:7OM1!IT8XES=VNE$6UL[KWZ4&9PAOX&RQ@A5*,4'M^,)#FGJ7\B? M/7MVKX;-]HOOUO&__JSRH+J^A=IN[M%)X6%DE]X)Z_XX3/>;:>=CQF>=__HH M_#D2_]72?P!02P$"% ,4 " =0$]4U=NW,ST# !# $0 M @ $ ;7)A:2TR,#(R,#(Q-2YX&UL4$L! A0#% @ '4!/5$FD*R=6!P R5@ !4 ( ! MG@X &UR86DM,C R,C R,35?<')E+GAM;%!+ 0(4 Q0 ( !U 3U2#E/-8 MW1( %!F 1 " 2<6 !T;3(R-C